CEO Omri Shor is tackling $300B problem of medication non-adherence by transforming behaviors, enabling better care through richer data, and connecting more points along the care continuum.
CEO Omri Shor is tackling $300B problem of medication non-adherence by transforming behaviors, enabling better care through richer data, and connecting more points along the care continuum.